論文

査読有り 国際誌
2021年7月5日

Uncovering a novel role of PLCβ4 in selectively mediating TCR signaling in CD8+ but not CD4+ T cells

Journal of Experimental Medicine
  • Miwa Sasai
  • Ji Su Ma
  • Masaaki Okamoto
  • Kohei Nishino
  • Hikaru Nagaoka
  • Eizo Takashima
  • Ariel Pradipta
  • Youngae Lee
  • Hidetaka Kosako
  • Pann-Ghill Suh
  • Masahiro Yamamoto
  • 全て表示

218
7
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1084/jem.20201763
出版者・発行元
Rockefeller University Press

Because of their common signaling molecules, the main T cell receptor (TCR) signaling cascades in CD4+ and CD8+ T cells are considered qualitatively identical. Herein, we show that TCR signaling in CD8+ T cells is qualitatively different from that in CD4+ T cells, since CD8α ignites another cardinal signaling cascade involving phospholipase C β4 (PLCβ4). TCR-mediated responses were severely impaired in PLCβ4-deficient CD8+ T cells, whereas those in CD4+ T cells were intact. PLCβ4-deficient CD8+ T cells showed perturbed activation of peripheral TCR signaling pathways downstream of IP3 generation. Binding of PLCβ4 to the cytoplasmic tail of CD8α was important for CD8+ T cell activation. Furthermore, GNAQ interacted with PLCβ4, mediated double phosphorylation on threonine 886 and serine 890 positions of PLCβ4, and activated CD8+ T cells in a PLCβ4-dependent fashion. PLCβ4-deficient mice exhibited defective antiparasitic host defense and antitumor immune responses. Altogether, PLCβ4 differentiates TCR signaling in CD4+ and CD8+ T cells and selectively promotes CD8+ T cell–dependent adaptive immunity.

リンク情報
DOI
https://doi.org/10.1084/jem.20201763
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/33970189
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111461
URL
http://rupress.org/jem/article-pdf/doi/10.1084/jem.20201763/1415036/jem_20201763.pdf
ID情報
  • DOI : 10.1084/jem.20201763
  • ISSN : 0022-1007
  • eISSN : 1540-9538
  • PubMed ID : 33970189
  • PubMed Central 記事ID : PMC8111461

エクスポート
BibTeX RIS